In a phase 2 clinical trial conducted on an obese population, over a 26-week period, patients who were administered a dose range of efinopegdutide from 5 mg to 10 mg experienced a weight reduction of up to 11.8%
[1] This characteristic has led to the widespread belief that vitamin B12 toxicity is virtually impossible
If youve noticed your energy, vitality and appearance declining with age, youre not alone
Headaches GLP-1-related headaches occur in a subset of users, typically during the first few weeks or after dose escalation
Under clinical supervision with proper selection and dosing, peptide therapy is generally well tolerated for appropriate candidates
It allows for accurate planning, budgeting, and execution